Evidence map›Paper›PMID 37440585›Full record

ReviewThe Journal of clinical endocrinology and metabolism2024

Obesity and Skeletal Fragility.

Rui Chen, Reina Armamento-Villareal

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in The Journal of clinical endocrinology and metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03887936 (Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism), which is not on this map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03887936 phase4completednot on this map

Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism

TypeinterventionalSponsorVA Office of Research and DevelopmentRan2019 to 2025Enrolled92ConditionsType 2 Diabetes Mellitus, HypogonadismArmsTestosterone gel 1.62%, Placebo
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Beyond Weight Loss: Skeletal Considerations in Obesity Treatment.Endocrinology and metabolism (Seoul, Korea) · 2026
    Review
  14. Associations between body composition and bone loss in early postmenopausal women.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
  15. The Intimate Relationship between Adipose Tissue, Fertility, and Bone.Journal of frailty, sarcopenia and falls · 2026
    Review
  16. Aging-Driven Inter-Organ Crosstalk in Postmenopausal Osteoporosis: From Immunometabolic Drift to Multisystem Frailty.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  17. Article
  18. Article
  19. Observational
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Rui ChenDivision of Endocrinology, Diabetes and Metabolism at Baylor College of Medicine, Houston, TX 77030, USA.
Reina Armamento-VillarealDivision of Endocrinology, Diabetes and Metabolism at Baylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-5956-4922
Michael E. DeBakey VA Medical Center · US

Funding

Aromatase Inhibitors and Weight Loss in Severely Obese Men with HypogonadismR01HD093047 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI VILLAREAL, REINA C · 2017 to 2022
$1.9M
Testosterone Therapy and Bone Quality in Men with Diabetes and HypogonadismI01CX001665 · VA · MICHAEL E DEBAKEY VA MEDICAL CENTER · PI VILLAREAL, REINA C · 2020 to 2025
–
CSRD VA I01 CX001665NICHD NIH HHS R01 HD093047NIH HHS R01 HD093047
6 · The paper itself

Abstract

Skeletal fracture has recently emerged as a complication of obesity. Given the normal or better than normal bone mineral density (BMD), the skeletal fragility of these patients appears to be a problem of bone quality rather than quantity. Type 2 diabetes mellitus (T2DM), the incidence of which increases with increasing body mass index, is also associated with an increased risk for fractures despite a normal or high BMD. With the additional bone pathology from diabetes itself, patients with both obesity and T2DM could have a worse skeletal profile. Clinically, however, there are no available methods for identifying those who are at higher risk for fractures or preventing fractures in this subgroup of patients. Weight loss, which is the cornerstone in the management of obesity (with or without T2DM), is also associated with an increased risk of bone loss. This review of the literature will focus on the skeletal manifestations associated with obesity, its interrelationship with the bone defects associated with T2DM, and the available approach to the bone health of patients suffering from obesity.

Indexed as

Diabetes Mellitus, Type 2Fractures, BoneBone and BonesBone DensityHumansObesitybonefracturesobesitytype 2 diabetes mellitusweight loss

Identifiers

PMID37440585
PMCPMC10795939
OpenAlexW4384277143

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.